Clinical characteristics and prognosis of patients with antiphospholipid antibodies based on cluster analysis: an 8-year cohort study

• Published in: Arthritis research & therapy Vol. 24; no. 1; pp. 140 - 13
• Main Authors: Qi, Wanting, Zhao, Jiuliang, Huang, Can, Jiang, Nan, Li, Jing, Wu, Chanyuan, Zhang, Shangzhu, Hu, Chaojun, Xu, Dong, Wang, Qian, Li, Mengtao, Tian, Xinping, Zhao, Yan, Zeng, Xiaofeng
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 11.06.2022; BioMed Central; BMC
• Subjects: Anemia; Antibodies; Anticoagulants; Antiphospholipid antibodies; Antiphospholipid syndrome; Arthritis; Asymptomatic; Autoimmune diseases; Body mass index; Cardiovascular disease; Cluster analysis; Cognitive ability; Cohort analysis; Health aspects; Heart; Heart disease risk factors; Hypertension; Lupus erythematosus, Systemic; Measurement; Medical imaging; Medical prognosis; Miscarriage; Morbidity; Obstetrics; Patient outcomes; Premature birth; Prognosis; Risk factors; Software; Statistical analysis; Thrombocytopenia; Thrombosis; Variables; China; Cluster analysis; Lupus erythematosus, Systemic; Heart disease risk factors; Morbidity; Antiphospholipid syndrome

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by persistent antiphospholipid antibodies (aPLs) positivity with a wide manifestation spectrum. A risk stratification is needed for management guidance and prognosis assessment. We aimed to identify phenotypes among aPL-positive...